-
SCC ctDNA sequencing
Study
EGAS00001003987
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma
Study
EGAS00001001665
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
A Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling
Study
EGAS00001004018
-
Analysis of enhancer-promoter connectivity alterations
Study
EGAS00001007411
-
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Study
EGAS00001004550
-
SS18-SSX-mediated hijacking of BAF complexes drives synovial sarcoma
Study
EGAS00001002920
-
Leeds Melanoma Cohort (LMC) gene expression study
Study
EGAS00001002922
-
RNA-seq of Ewing sarcoma tumors (ICGC)
Study
EGAS00001003333
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Whole exome sequencing CYLD cutaneous syndrome
Study
EGAS00001003839
-
Targeted sequencing CYLD cutaneous syndrome
Study
EGAS00001003840
-
Osteosarcoma mate-pair and RNA-sequencing
Study
EGAS00001003842
-
Genome-wide discovery of somatic coding and regulatory variants in Diffuse Large B-cell Lymphoma
Study
EGAS00001002936
-
Whole-exome sequencing and microRNA profiling predicted relapse risk of stage I lung adenocarcinomas
Study
EGAS00001004461
-
A Single-Cell Atlas of the Multicellular Ecosystem of Primary and Metastatic Hepatocellular Carcinoma
Study
EGAS00001004468
-
Mutational Landscape of Grey Zone Lymphoma
Study
EGAS00001004482
-
Colorectal advanced adenomas NKI-AvL TGO COCOS series
Study
EGAS00001002952
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Study
EGAS00001002967
-
Breast implant-associated anaplastic large cell lymphoma shallow whole genome sequencing for copy number analysis and Whole exome sequencing data.
Study
EGAS00001003962
-
Whole-exome sequencing of intravascular large B-Cell lymphoma
Study
EGAS00001003970
-
Spiradenocarcinoma
Study
EGAS00001001799